Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-27
2007-03-27
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S330000, C514S315000, C546S272100, C546S268100, C546S193000
Reexamination Certificate
active
10848743
ABSTRACT:
The present invention is directed to the compound of formula I which is useful for inhibiting the activity of Factor Xa. The present invention is also directed to compositions containing said compounds, processes for their preparation, their use, such as for inhibiting the formation of thrombin or for therapeutically or prophylactically treating a patient suffering from, or subject to, or associated with a disease state associated with a cardiovascular disorder.
REFERENCES:
patent: 6287794 (2001-09-01), Safar et al.
patent: 6337344 (2002-01-01), Defossa et al.
patent: 6906084 (2005-06-01), Nazaré et al.
patent: 6953857 (2005-10-01), Nazaré et al.
patent: 7022716 (2006-04-01), Hu et al.
patent: 7026348 (2006-04-01), Mihelich et al.
patent: 7030123 (2006-04-01), Arnould et al.
patent: 7030143 (2006-04-01), Kuwabara et al.
patent: 7049323 (2006-05-01), Chaturvedula et al.
patent: 7053070 (2006-05-01), Booth et al.
patent: 7064135 (2006-06-01), Dorwald
patent: 7067665 (2006-06-01), Nazaréet al.
patent: 7078419 (2006-07-01), Cirillo et al.
patent: 2003/0165837 (2003-09-01), Boger
patent: 2004/0043995 (2004-03-01), Bignon et al.
patent: 2004/0171604 (2004-09-01), Nazaréet al.
patent: 2004/0204406 (2004-10-01), Nazaréet al.
patent: 2004/0235824 (2004-11-01), Nazaréet al.
patent: 2005/0009827 (2005-01-01), Nazaréet al.
patent: 2005/0009829 (2005-01-01), Nazaréet al.
patent: 2005/0033049 (2005-02-01), Nazaréet al.
patent: 2005/0043302 (2005-02-01), Nazaréet al.
patent: 0 186 367 (1986-07-01), None
patent: WO 92/06711 (1992-04-01), None
patent: WO 93/25524 (1993-12-01), None
patent: WO 95/29189 (1995-11-01), None
patent: WO 96/12800 (1996-05-01), None
patent: WO 97/47651 (1997-12-01), None
patent: WO 99/33800 (1999-07-01), None
patent: WO 01/30775 (2001-05-01), None
patent: WO 01/64639 (2001-09-01), None
patent: WO 03/028719 (2003-04-01), None
U.S. Appl. No. 10/301,397, filed Nov. 21, 2002, Nazaré.
U.S. Appl. No. 10/926,909, filed Aug. 26, 2004, Nazaré.
U.S. Appl. No. 09/363,196, filed Jul. 28, 1999, Ewing.
Adang Anton E P et al., A New Generation of Orally Active Antithrombotics: Comparing Strategies in the GPIIb/IIIa, Thrombin and Factor Xa Areas, Drugs of the Future 2000; vol. 25(4); pp. 396-383.
Beswick, P. et al. , The Synthesis of 4—Substituted Indoles via Arenetricarbonylchromium(0) Complexes, Tetrahedron vol. 44, No. 23, pp. 7325-7334, (1988).
Bornstein, et. al. , Facile Hydrolysis of the Trifluoromethyl Group in the Presence of Base. Some Trifluoromethylated Indoles, J. Amer. Chem. Soc. 79 (1957) 1745.
Brennan Mary R et al., The Preparation and Spectral Characterization of 2-Haloindoles, 3-Haloindoles, and 2,3-Dihaloindoles, Heterocycles, 1986, vol. 24, No. 10, pp. 2879-2885.
Bundgaard, Hans, Novel Chemical Approaches in Prodrug Design, Drugs of the Future, (1991), vol. 16, No. 5, pp. 443-458.
Burton Harold et al., The Synthesis of 5- and 6-Benzyloxyindoles and Attempts to prepare 5- and 6-Hydroxyindoles therefrom, J. Chem. Society, 1937, pp. 1726-1728.
Caddick, et al., Microwave Assisted Organic Reactions, Tetrahedron; 51; 1995; pp. 10403-10432.
Chan Dominic M T et al., New N- and O-Arylations with Phenylboronic Acids and Cupric Acetate, Tetrahedron Letters, 1998, vol. 39, pp. 2933-2936.
Chen, Cheng-yi et al., Syntheses of Indoles via a Palladium-Catalyzed Annulation between Iodoanilines and Ketones, J. Org. Chem., 1997, vol. 62, pp. 2676-2677.
Cheng Yung-Chi et al., Relationship Between the Inhibition Constant (K1) and the Concentration of Inhibitor which causes 50 per cent Inhibition (I 50) of an Enzymatic Reaction, Biochem. Pharmacol., 1973, vol. 22, pp. 3099-3108.
Chikvaidze J Sh et al, Indole Derivatives, Khim. Geterotsikl. Soedin, 1991, Bol. 11, pp. 1508-1511.
Collot, et al., Regiospecific Functionalization of Indole-2-Carboxylates and Diastereoselective Preparation of the Corresponding Indolines, Heterocycles; 51; 12; 1999; pp. 2823-2846.
Comins Daniel L et al., N-Methyl Lithiation of N-Methylindoles Directed by a-Amino Alkoxides, Tetrahedron Letters, 1989, vol. 30, No. 33, pp. 4337-4340.
Desarbre, E. et al., Synthesis of 2-Substituted-1H-Pyrrolo[2,3-b]Pyridines: Preparation of 7-Azaolivacine Analogue and 7-Azaindolopyridopyrimidine Derivatives., Tetrahedron vol. 53 No. 10 (1997) pp. 3637-3648.
Dormoy, J.-R. et al., Synthese Industrielle En Series Ellipticine. , Tetrahedron vol. 49 No. 14 (1993) pp. 2885-2914.
Ezquerra Jesús et al., Efficient Reagents for the Synthesis of 5-, 7-, and 5,7-Substituted Indoles Starting from Aromatic Amines; Scope and Limitations, J. Org. Chem., 1996, vol. 61, pp. 5804-5812.
Fleisher David et al., Improved Oral Drug Delivery: Solubility Limitations Overcome by the Use of Prodrugs, Advanced Drug Delivery Reviews; 1996; vol. 19; pp. 115-130.
Gray Nancy M et al., Novel Indole-2-Carboxylates as Ligands for the Strychnine-Insensitive N-Methyl-D-aspartate-Linked Glycine Receptor, J. Med. Chem., 1991, vol. 34, pp. 1238-1292.
Hartwig John F et al., Room-Temperature Palladium-Catalyzed Amination of Aryl Bromides and Chlorides and Extended Scope of Aromatic C-N Bond Formation with a Commercial Ligand, J. Org. Chem., 1999, vol. 64, pp. 5575-5580.
Hasan Iltifat et al., Synthesis and Reactions of N-Protected 2-Lithiated Pyrroles and Indoles. The tert-Butoxycarbonyl Substituent as a Protecting Group, J. Org. Chem., 1981, vol. 46, pp. 157-164.
Hiremath Shivayogi P et al., Synthesis & Reaction of Indole-1,2-Dicarboxaldehydes with Hydrazine & Hydroxylamine, Indian J. of Chemistry. 1980, vol. 19B, pp. 770-774.
Khanna Ish K et al., 1,2-Diarylimidazoles as Potent, Cyclooxygenase-2 Selective, and Orally Active Antiinflammatory Agents, J. Med. Chem., 1997, vol. 40, pp. 1634-1647.
Kline Toni, Preparation of 2-Iodotryptamine and 2-lodo-5-methoxytryptamine, J. Heterocycl. Chem., 1985, vol. 22, pp. 505-509.
Krstenansky, et al., Recent Advances in Microwave-assisted Organic Synthesis, Current Opinion in Drug Discovery & Development; 3(4); 2000; pp. 454-461.
Kuneri, M., Indole-related compounds. IV The reaction of Phosphorus pentachloride with Ethyl indole-2-carboxylate., Chem. Abstr. (1962) pp. 3441i-3442b.
Kwong, F. et al. , Copper-Catalyzed Coupling of Alkylamines and Aryl Iodides: An Efficient System Even in an Air Atmosphere, Organic Letters vol. 4 No. 4 (2002) pp. 581-584.
Lam Patrick Y S et al., New Aryl/Heteroaryl C-N Bond Cross-coupling Reactions via Arylboronic Acid/Cupric Acetate Arylation, Tetrahedron Letters, 1998, vol. 39, pp. 2941-2944.
Larhed, et al., Microwave-assisted high-speed chemistry: a new technique in drug discovery, Drug Discovery Today; 8; 2001; pp. 406-416.
Larock, R., et al., Synthesis of Indoles via Palladium-Catalyzed Heteroannulation of Internal Alkynes, J.Am. Chem. Soc. vol. 113 (1991) pp. 6689-6690.
Lidstrom, et al., Microwave assisted organic synthesis—a review, Tetrahedron; 57; 2001; pp. 9225-9283.
Lindwall H G et al., Synthesis and Reactions of Indole Carboxylic Acids; Pyridindolones from Indole-2-Carboxyacetalylbenzylamides, J. Org. Chem., 1953, vol. 18, pp. 345-357.
Mann, et al., Palladium-Catalyzed C-N(sp2) Bond Formation: N-Arylation Of Aromatic And Unsaturated Nitrogen And The Reductive Elimination Chemistry Of Palladium Azolyl And Methyleneamido Complexes, J. Am. Chem. Soc. (1998), 120, 827-828.
Matter, Hans et al., Design and Quantitative Structure—Activity Relationship of 3-Amidinobenzyl-1H-indole-2-carboxamides as Potent, Nonchiral, and Selective Inhibitors of Blood Congestion Factor Xa, Journal of Medicinal Chemistry, (2002), vol. 45, pp. 2749-2769.
Mederski Werner W K R et al., N-Aryl Heterocycles via Coupling Reactions with Arylboronic Acids, Tetrahedron, 1999, vol. 55, pp. 12757-12770.
Murakami Yasuoki et al., p-Toluenesulfonic Acid and Cation Exchange Resin in Aprotic Solvent: Valuable Catalysts for Fischer Indolization, Heterocycles, 1984, vol. 22, No. 5, pp. 1211-1216.
Nichols David E et al., 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: A Potent Serotonin 5-HT 2A/2C Agonist, J. Med. Chem., 1994, vol.
Laux Volker
Nazare Marc
Ritter Kurt
Wehner Volkmar
Knight Julie Anne
Lambkin Deborah C.
Lin Jiang
Rossi Joseph R.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Indole derivatives as factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives as factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives as factor Xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3730305